thyroid cancer
OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing
The companies are working together to offer next-generation sequencing-based molecular testing on thyroid cancer biopsies to clinicians in Italy.
Thermo Fisher Gets FDA OK for CDx Test to Guide Use of Lilly Drug in Lung, Thyroid Cancers
The NGS-based Oncomine Dx Target Test will help ID patients with advanced RET-driven lung and thyroid cancers who may be eligible for treatment with Eli Lilly's Retevmo.
Genetron Health Adds New Assays to Pipeline While Anticipating MRD Launch, Liver Cancer Kit Trials
Premium
As it eyes new targets, the firm is poised to launch its personalized solid tumor MRD assay this year and is progressing toward approval for a liver cancer early detection IVD.
Interpace Biosciences Says CMS to Cover Thyroid Tests, Reversing Earlier Decision
CMS previously said it would no longer reimburse for the ThyGeNext and ThyraMir tests when the tests are billed together.
CMS No Longer Reimbursing Interpace Bio Thyroid Tests; Firm's Rights Offering Terminated
CMS has issued a new billing policy and will no longer reimburse for the use of Interpace's ThyGeNext and ThyraMir thyroid cancer tests under certain conditions.